Glucuronyl C5-epimerase, DNA encoding the same and uses thereof

Details for Australian Patent Application No. 2002217174 (hide)

Owner Biotie Therapies Corp.

Inventors El Darwish, Kamel; Li, Jin-ping; Lindahl, Ulf; Jalkanen, Markku

Agent Ahearn Fox

Pub. Number AU-B-2002217174

PCT Pub. Number WO02/46379

Priority 60/304,180 08.12.00 US

Filing date 7 December 2001

Wipo publication date 18 June 2002

Acceptance publication date 22 June 2006

International Classifications

C12N 9/90 (2006.01) Enzymes, e.g. ligases (6.) - Isomerases (5.)

Event Publications

22 June 2006 Application Accepted

  Published as AU-B-2002217174

19 October 2006 Standard Patent Sealed

30 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002217175-A method for manufacturing paper with a constant filler content

2002217173